First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases.
Chloe I BloomJukka MontonenOlaf JönsElizabeth M GarrySurya P BhattPublished in: Pulmonary therapy (2022)
At 1MT, two-thirds of patients in the US received ICS-containing therapies, with almost half on LABA/ICS. In contrast, less than one-third received ICS-containing therapy in the UK and more than half of patients received LAMA. In both countries, more patients received ICS-containing therapies at initiation of 1MT than would be expected based on their exacerbation history, suggesting overprescribing.
Keyphrases
- end stage renal disease
- chronic obstructive pulmonary disease
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- magnetic resonance
- stem cells
- intensive care unit
- social media
- machine learning
- mesenchymal stem cells
- air pollution
- cell therapy
- acute respiratory distress syndrome
- patient reported